These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35169702)

  • 1. A candidate neuroimaging biomarker for detection of neurotransmission-related functional alterations and prediction of pharmacological analgesic response in chronic pain.
    Martins D; Veronese M; Turkheimer FE; Howard MA; Williams SCR; Dipasquale O
    Brain Commun; 2022; 4(1):fcab302. PubMed ID: 35169702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Connectivity Predicts Placebo Response across Chronic Pain Clinical Trials.
    Tétreault P; Mansour A; Vachon-Presseau E; Schnitzer TJ; Apkarian AV; Baliki MN
    PLoS Biol; 2016 Oct; 14(10):e1002570. PubMed ID: 27788130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inferring distinct mechanisms in the absence of subjective differences: Placebo and centrally acting analgesic underlie unique brain adaptations.
    Tétreault P; Baliki MN; Baria AT; Bauer WR; Schnitzer TJ; Apkarian AV
    Hum Brain Mapp; 2018 May; 39(5):2210-2223. PubMed ID: 29417694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
    Carter NJ; McCormack PL
    CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA.
    Dipasquale O; Selvaggi P; Veronese M; Gabay AS; Turkheimer F; Mehta MA
    Neuroimage; 2019 Jul; 195():252-260. PubMed ID: 30953835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
    Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
    Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data.
    Wang G; Bi L; Li X; Li Z; Zhao D; Chen J; He D; Wang CN; Wu T; Dueñas H; Skljarevski V; Yue L
    BMC Musculoskelet Disord; 2019 Apr; 20(1):174. PubMed ID: 31010413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.
    Chappell AS; Ossanna MJ; Liu-Seifert H; Iyengar S; Skljarevski V; Li LC; Bennett RM; Collins H
    Pain; 2009 Dec; 146(3):253-260. PubMed ID: 19625125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Differential Pharmacologic Response in Chronic Pain Using Functional Neuroimaging Biomarkers and a Support Vector Machine Algorithm: An Exploratory Study.
    Ichesco E; Peltier SJ; Mawla I; Harper DE; Pauer L; Harte SE; Clauw DJ; Harris RE
    Arthritis Rheumatol; 2021 Nov; 73(11):2127-2137. PubMed ID: 33982890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine and Subacute Pain after Knee Arthroplasty when Added to a Multimodal Analgesic Regimen: A Randomized, Placebo-controlled, Triple-blinded Trial.
    YaDeau JT; Brummett CM; Mayman DJ; Lin Y; Goytizolo EA; Padgett DE; Alexiades MM; Kahn RL; Jules-Elysee KM; Fields KG; Goon AK; Gadulov Y; Westrich G
    Anesthesiology; 2016 Sep; 125(3):561-72. PubMed ID: 27387351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salience, central executive, and sensorimotor network functional connectivity alterations in failed back surgery syndrome.
    Kolesar TA; Bilevicius E; Kornelsen J
    Scand J Pain; 2017 Jul; 16():10-14. PubMed ID: 28850382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive fatigue in multiple sclerosis is associated with alterations in the functional connectivity of monoamine circuits.
    Cercignani M; Dipasquale O; Bogdan I; Carandini T; Scott J; Rashid W; Sabri O; Hesse S; Rullmann M; Lopiano L; Veronese M; Martins D; Bozzali M
    Brain Commun; 2021; 3(2):fcab023. PubMed ID: 33842886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies.
    Enomoto H; Fujikoshi S; Funai J; Sasaki N; Ossipov MH; Tsuji T; Alev L; Ushida T
    J Pain Res; 2017; 10():1357-1368. PubMed ID: 28615967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serotonin transporter occupancies and analgesic effects of AS1069562, the (+)-isomer of indeloxazine, and duloxetine in reserpine-induced myalgia rats.
    Murai N; Fushiki H; Honda S; Murakami Y; Iwashita A; Irie M; Tamura S; Nagakura Y; Aoki T
    Neuroscience; 2015 Mar; 289():262-9. PubMed ID: 25595980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled, double-blinded trial of duloxetine in the treatment of general fatigue in patients with chronic fatigue syndrome.
    Arnold LM; Blom TJ; Welge JA; Mariutto E; Heller A
    Psychosomatics; 2015; 56(3):242-53. PubMed ID: 25660434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressants normalize the default mode network in patients with dysthymia.
    Posner J; Hellerstein DJ; Gat I; Mechling A; Klahr K; Wang Z; McGrath PJ; Stewart JW; Peterson BS
    JAMA Psychiatry; 2013 Apr; 70(4):373-82. PubMed ID: 23389382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials.
    Micca JL; Ruff D; Ahl J; Wohlreich MM
    BMC Musculoskelet Disord; 2013 Apr; 14():137. PubMed ID: 23590727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial.
    Matthey A; Cedraschi C; Piguet V; Besson M; Chabert J; Daali Y; Courvoisier D; Montagne A; Dayer P; Desmeules JA
    Pain Physician; 2013; 16(5):E553-62. PubMed ID: 24077206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine in OsteoArthritis (DOA) study: effects of duloxetine on pain and function in end-stage hip and knee OA - a pragmatic enriched randomized controlled trial.
    Blikman T; Rienstra W; van Raaij TM; Ten Hagen AJ; Dijkstra B; Zijlstra WP; Bulstra SK; Stevens M; van den Akker-Scheek I
    BMC Musculoskelet Disord; 2022 Feb; 23(1):115. PubMed ID: 35123461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging.
    Wanigasekera V; Wartolowska K; Huggins JP; Duff EP; Vennart W; Whitlock M; Massat N; Pauer L; Rogers P; Hoggart B; Tracey I
    Br J Anaesth; 2018 Feb; 120(2):299-307. PubMed ID: 29406179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.